お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書はサイトメガロウイルス感染症市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはサイトメガロウイルス感染症の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界のサイトメガロウイルス感染症市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはサイトメガロウイルス感染症のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にサイトメガロウイルス感染症市場を分類しています。本研究に含まれる主な企業は：Roche、GlaxoSmithKline、Vical、AiCuris Anti-Infective Cures、ViroPharma、Chimerix

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Cidofovir
    Foscarnet
    Valganciclovir
    Ganciclovir

用途別の市場セグメント：
    Hospitals
    Retail Pharmacies
    Online Pharmacies

本レポートの詳細内容
世界のサイトメガロウイルス感染症市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、サイトメガロウイルス感染症タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のサイトメガロウイルス感染症収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のサイトメガロウイルス感染症市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、サイトメガロウイルス感染症市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

サイトメガロウイルス感染症のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：サイトメガロウイルス感染症のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：サイトメガロウイルス感染症の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章サイトメガロウイルス感染症企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：サイトメガロウイルス感染症の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：サイトメガロウイルス感染症の主要企業の概要を提供し、製品の説明と仕様、サイトメガロウイルス感染症の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Cytomegalovirus (CMV) infection is one of the common herpesvirus infection with different symptoms, which occurs in people of all ages across the globe. This viral infection is communicable and can easily spread through body fluids such as blood, urine, saliva, semen and breast milk. The infection can spread easily through saliva or urine and the people infected with the CMV may have the virus in their saliva or urine for months. The disease can be transmitted from pregnant women to the baby during the delivery. Blood transfusion and infected organ transplant is yet another mode of disease transmission.
Market Analysis and Insights: Global Cytomegalovirus Infection Market
The global Cytomegalovirus Infection market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The key factor responsible for growth of cytomegalovirus infection is increasing public awareness related to herpes virus infections which is fueling the diagnosis rate in North America and Europe. North America was observed as the largest market for cytomegalovirus infection treatment followed by Europe. Asia Pacific was anticipated to grow at a fastest CAGR during the forecast period. The key factors assisting the growth of Asia Pacific cytomegalovirus infection treatment market are the rising awareness associated with the rare diseases, developing healthcare infrastructure, high disposable income and government support for novel treatment against rare genetic diseases.
Report Covers:
This report presents an overview of global market for Cytomegalovirus Infection market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Cytomegalovirus Infection, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cytomegalovirus Infection, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cytomegalovirus Infection revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Cytomegalovirus Infection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Cytomegalovirus Infection revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Roche, GlaxoSmithKline, Vical, AiCuris Anti-Infective Cures, ViroPharma and Chimerix, etc.

Market Segmentation
By Company
    Roche
    GlaxoSmithKline
    Vical
    AiCuris Anti-Infective Cures
    ViroPharma
    Chimerix

Segment by Type
    Cidofovir
    Foscarnet
    Valganciclovir
    Ganciclovir

Segment by Application
    Hospitals
    Retail Pharmacies
    Online Pharmacies

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cytomegalovirus Infection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cytomegalovirus Infection companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cytomegalovirus Infection revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Cytomegalovirus Infection Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Cidofovir
    Table 3. Key Players of Foscarnet
    Table 4. Key Players of Valganciclovir
    Table 5. Key Players of Ganciclovir
    Table 6. Global Cytomegalovirus Infection Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Cytomegalovirus Infection Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Cytomegalovirus Infection Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Cytomegalovirus Infection Market Share by Region (2019-2024)
    Table 10. Global Cytomegalovirus Infection Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Cytomegalovirus Infection Market Share by Region (2025-2030)
    Table 12. Cytomegalovirus Infection Market Trends
    Table 13. Cytomegalovirus Infection Market Drivers
    Table 14. Cytomegalovirus Infection Market Challenges
    Table 15. Cytomegalovirus Infection Market Restraints
    Table 16. Global Cytomegalovirus Infection Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Cytomegalovirus Infection Revenue Share by Players (2019-2024)
    Table 18. Global Top Cytomegalovirus Infection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytomegalovirus Infection as of 2023)
    Table 19. Global Cytomegalovirus Infection Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Cytomegalovirus Infection Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Cytomegalovirus Infection, Headquarters and Area Served
    Table 22. Global Key Players of Cytomegalovirus Infection, Product and Application
    Table 23. Global Key Players of Cytomegalovirus Infection, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Cytomegalovirus Infection Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Cytomegalovirus Infection Revenue Market Share by Type (2019-2024)
    Table 27. Global Cytomegalovirus Infection Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Cytomegalovirus Infection Revenue Market Share by Type (2025-2030)
    Table 29. Global Cytomegalovirus Infection Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Cytomegalovirus Infection Revenue Share by Application (2019-2024)
    Table 31. Global Cytomegalovirus Infection Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Cytomegalovirus Infection Revenue Share by Application (2025-2030)
    Table 33. North America Cytomegalovirus Infection Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Cytomegalovirus Infection Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Cytomegalovirus Infection Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Cytomegalovirus Infection Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Cytomegalovirus Infection Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Cytomegalovirus Infection Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Cytomegalovirus Infection Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Cytomegalovirus Infection Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Cytomegalovirus Infection Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Cytomegalovirus Infection Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Cytomegalovirus Infection Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Cytomegalovirus Infection Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Cytomegalovirus Infection Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Cytomegalovirus Infection Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Cytomegalovirus Infection Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Cytomegalovirus Infection Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Cytomegalovirus Infection Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Cytomegalovirus Infection Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Cytomegalovirus Infection Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Cytomegalovirus Infection Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Cytomegalovirus Infection Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Cytomegalovirus Infection Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Cytomegalovirus Infection Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Cytomegalovirus Infection Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Cytomegalovirus Infection Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Cytomegalovirus Infection Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Cytomegalovirus Infection Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Cytomegalovirus Infection Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Cytomegalovirus Infection Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Cytomegalovirus Infection Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Cytomegalovirus Infection Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Cytomegalovirus Infection Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Roche Company Details
    Table 66. Roche Business Overview
    Table 67. Roche Cytomegalovirus Infection Product
    Table 68. Roche Revenue in Cytomegalovirus Infection Business (2019-2024) & (US$ Million)
    Table 69. Roche Recent Developments
    Table 70. GlaxoSmithKline Company Details
    Table 71. GlaxoSmithKline Business Overview
    Table 72. GlaxoSmithKline Cytomegalovirus Infection Product
    Table 73. GlaxoSmithKline Revenue in Cytomegalovirus Infection Business (2019-2024) & (US$ Million)
    Table 74. GlaxoSmithKline Recent Developments
    Table 75. Vical Company Details
    Table 76. Vical Business Overview
    Table 77. Vical Cytomegalovirus Infection Product
    Table 78. Vical Revenue in Cytomegalovirus Infection Business (2019-2024) & (US$ Million)
    Table 79. Vical Recent Developments
    Table 80. AiCuris Anti-Infective Cures Company Details
    Table 81. AiCuris Anti-Infective Cures Business Overview
    Table 82. AiCuris Anti-Infective Cures Cytomegalovirus Infection Product
    Table 83. AiCuris Anti-Infective Cures Revenue in Cytomegalovirus Infection Business (2019-2024) & (US$ Million)
    Table 84. AiCuris Anti-Infective Cures Recent Developments
    Table 85. ViroPharma Company Details
    Table 86. ViroPharma Business Overview
    Table 87. ViroPharma Cytomegalovirus Infection Product
    Table 88. ViroPharma Revenue in Cytomegalovirus Infection Business (2019-2024) & (US$ Million)
    Table 89. ViroPharma Recent Developments
    Table 90. Chimerix Company Details
    Table 91. Chimerix Business Overview
    Table 92. Chimerix Cytomegalovirus Infection Product
    Table 93. Chimerix Revenue in Cytomegalovirus Infection Business (2019-2024) & (US$ Million)
    Table 94. Chimerix Recent Developments
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cytomegalovirus Infection Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Cytomegalovirus Infection Market Share by Type: 2023 VS 2030
    Figure 3. Cidofovir Features
    Figure 4. Foscarnet Features
    Figure 5. Valganciclovir Features
    Figure 6. Ganciclovir Features
    Figure 7. Global Cytomegalovirus Infection Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Cytomegalovirus Infection Market Share by Application: 2023 VS 2030
    Figure 9. Hospitals Case Studies
    Figure 10. Retail Pharmacies Case Studies
    Figure 11. Online Pharmacies Case Studies
    Figure 12. Cytomegalovirus Infection Report Years Considered
    Figure 13. Global Cytomegalovirus Infection Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Cytomegalovirus Infection Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Cytomegalovirus Infection Market Share by Region: 2023 VS 2030
    Figure 16. Global Cytomegalovirus Infection Market Share by Players in 2023
    Figure 17. Global Top Cytomegalovirus Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytomegalovirus Infection as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Cytomegalovirus Infection Revenue in 2023
    Figure 19. North America Cytomegalovirus Infection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Cytomegalovirus Infection Market Share by Type (2019-2030)
    Figure 21. North America Cytomegalovirus Infection Market Share by Application (2019-2030)
    Figure 22. North America Cytomegalovirus Infection Market Share by Country (2019-2030)
    Figure 23. United States Cytomegalovirus Infection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Cytomegalovirus Infection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Cytomegalovirus Infection Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Cytomegalovirus Infection Market Share by Type (2019-2030)
    Figure 27. Europe Cytomegalovirus Infection Market Share by Application (2019-2030)
    Figure 28. Europe Cytomegalovirus Infection Market Share by Country (2019-2030)
    Figure 29. Germany Cytomegalovirus Infection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Cytomegalovirus Infection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Cytomegalovirus Infection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Cytomegalovirus Infection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Cytomegalovirus Infection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Cytomegalovirus Infection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Cytomegalovirus Infection Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Cytomegalovirus Infection Market Share by Type (2019-2030)
    Figure 37. China Cytomegalovirus Infection Market Share by Application (2019-2030)
    Figure 38. Asia Cytomegalovirus Infection Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Cytomegalovirus Infection Market Share by Type (2019-2030)
    Figure 40. Asia Cytomegalovirus Infection Market Share by Application (2019-2030)
    Figure 41. Asia Cytomegalovirus Infection Market Share by Region (2019-2030)
    Figure 42. Japan Cytomegalovirus Infection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Cytomegalovirus Infection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Cytomegalovirus Infection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Cytomegalovirus Infection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Cytomegalovirus Infection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Cytomegalovirus Infection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Cytomegalovirus Infection Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Cytomegalovirus Infection Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Cytomegalovirus Infection Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Cytomegalovirus Infection Market Share by Country (2019-2030)
    Figure 52. Brazil Cytomegalovirus Infection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Cytomegalovirus Infection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Cytomegalovirus Infection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Cytomegalovirus Infection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Cytomegalovirus Infection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Cytomegalovirus Infection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Roche Revenue Growth Rate in Cytomegalovirus Infection Business (2019-2024)
    Figure 59. GlaxoSmithKline Revenue Growth Rate in Cytomegalovirus Infection Business (2019-2024)
    Figure 60. Vical Revenue Growth Rate in Cytomegalovirus Infection Business (2019-2024)
    Figure 61. AiCuris Anti-Infective Cures Revenue Growth Rate in Cytomegalovirus Infection Business (2019-2024)
    Figure 62. ViroPharma Revenue Growth Rate in Cytomegalovirus Infection Business (2019-2024)
    Figure 63. Chimerix Revenue Growth Rate in Cytomegalovirus Infection Business (2019-2024)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed